-
A Different Approach to the Overall Survival Conversation: A Bayesian Analysis of Overall Survival Benefits Among Oncology Accelerated Approvals
Mar 10, 2025, 14:00 PM -
Challenges in Projecting Treatment Journeys for ALK-mutated NSCLC: Addressing Uncertainty in PPS and Immature Overall Survival Data
Mar 10, 2025, 14:00 PM -
Moving Beyond Partitioned Survival Models in Oncology Submissions: Incorporation of Canada's Drug Agency Guidance on Model Structure
Mar 10, 2025, 14:00 PM -
Estimating the Effect of a Discontinued Amyotrophic Lateral Sclerosis Treatment on Time-to-Death Using Sequential Target Trial Emulation
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Tisagenlecleucel for Third-Line Treatment With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients
Mar 10, 2025, 14:00 PM -
Hypertrophic Scar Severity and Clinical Management in the Real-World Dermatology Setting
Mar 10, 2025, 14:00 PM -
Payer Archetypes and Decision-Making in the United States (US): A framework for Generalised Cost-Effectiveness Analysis (GCEA) Value Elements to Optimize Patient Access and Equity
Mar 10, 2025, 14:00 PM -
Prisoners’ Preferences for Virtual Care Design and Delivery in the Correctional Setting: A Discrete Choice Experiment
Mar 10, 2025, 14:00 PM -
Leveraging Social Media Listening and AI: Topic Modeling and RAG Approaches to Analyse Pet Owners' Perspectives on Nonsteroidal Anti-Inflammatory Drugs in Animal Health
Mar 10, 2025, 14:00 PM -
Economic Savings Associated with Surgical Mitral Valve Replacement with a Novel Bovine Bioprosthesis
Mar 10, 2025, 14:00 PM -
Economic Evaluation of NT-proBNP Testing to Facilitate Prevention of Heart Failure in Adults With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Investing in Clinical Guidelines to Enhance Health Technology Assessments and Reimbursement Decisions
Mar 10, 2025, 14:00 PM -
Development and Validation of a Machine Learning-based screening Algorithm to Predict High Risk of Hepatitis C Infection
Mar 10, 2025, 14:00 PM -
Adapting Global Cost-Effectiveness Models for Low- and Middle-Income Countries: Key Learnings and Challenges Addressed
Mar 10, 2025, 14:00 PM -
Validity and Accuracy of Asthma-Related ICD-10 Diagnosis Codes in United States Real-World Administrative Database
Mar 10, 2025, 14:00 PM -
From Data to Actionable Insight: A Collaborative Monitoring & Evaluation (M&E) Initiative Convened by Canada’s Drug Agency (CDA-AMC) - Piloting Plans for Diabetes and Contraception
Mar 10, 2025, 14:00 PM -
Augmenting Race and Ethnicity in a Real-World Oncology Cohort Using the Bayesian Improved Surname Geocoding Methodology
Mar 10, 2025, 14:00 PM -
Use of Health Technology Assessments in Specialty Drug Coverage Decisions by U.S. Commercial Health Plans
Mar 10, 2025, 14:00 PM -
Considerations for Health Economic Modeling in Phenylketonuria (PKU): Insights From a Modified Delphi Panel
Mar 10, 2025, 14:00 PM -
Healthcare Across Borders: Changes in Physician Numbers and Spatial Inequalities in Hungary and the DACH Countries (Austria, Germany, Switzerland)
Mar 10, 2025, 14:00 PM
